Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05175521 · ClinicalTrials.gov registry record · NA
Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine
A NA study of Migraine, sponsored by HonorHealth Research Institute.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05175521: Active NA study of Migraine, sponsored by HonorHealth Research Institute.
NCT05175521 is a NA study of Migraine that is active but no longer recruiting, run by HonorHealth Research Institute. The registered enrollment target is 50 participants, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05175521, a NA study of Migraine, is active but no longer recruiting, sponsored by HonorHealth Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to compare the efficacy and adverse events of inhaled isopropyl alcohol vapor (IAV) versus placebo (inhaled eucalyptus scent (IES) (1:20 dilution in mineral oil) for treating nausea associated with acute migraine attacks.
Primary Outcome
Change in Nausea, modified visual analog score from 0-10 with 10 severe nausea with vomiting, 5 moderate nausea, 1 mild nausea and 0 no nausea.
Conditions Studied
Interventions
- OTHER Eucalyptus Oil Scent
- OTHER Isopropyl Alcohol Vapors
Study Locations (1)
Arizona
- HonorHealth Bob Bové Neuroscience Institute - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-11-11 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
What the registry record for NCT05175521 still lists
NCT05175521 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Migraine appearing as the primary indexed condition, and to 2 interventions - of which Eucalyptus Oil Scent is the first listed.
NCT05175521 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT05175521 about?
NCT05175521 is a clinical study titled "Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine". The goal of this study is to compare the efficacy and adverse events of inhaled isopropyl alcohol vapor (IAV) versus placebo (inhaled eucalyptus scent (IES) (1:20 dilution in mineral oil) for treating nausea associated with acute migraine attacks.
What is the current status of trial NCT05175521?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2021-11-11. Estimated completion is 2026-01-31.
What conditions does trial NCT05175521 study?
This clinical trial studies the following conditions: Migraine.
What interventions are being tested in trial NCT05175521?
The interventions under investigation include: Eucalyptus Oil Scent (OTHER), Isopropyl Alcohol Vapors (OTHER).
Who is sponsoring clinical trial NCT05175521?
This trial is sponsored by HonorHealth Research Institute, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05175521 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05175521's enrollment target sits among peer trials
50 82nd of 102 higher than 19 of 102 other Migraine trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Migraine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MMA Embolization for Refractory Chronic Migraine
RECRUITING · NA
-
Stimulation of External Carotid Artery Circulation
RECRUITING · NA
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Cocoa Extract for Migraine Trial
RECRUITING · NA
-
Migraine in Adolescents
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI